SHERILYN RITTGERS: Open Payments
NPI 1588399026 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 24 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $543 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| ABBVIE INC. | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Tris Pharma Inc | 4 | $69 |
| Corium, LLC | 3 | $59 |
| Lundbeck LLC | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Neos Therapeutics, LP | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Azstarys, Dyanavel XR, HETLIOZ, Adzenys XR-ODT, Jornay PM.
Industry payments across IA — which companies pay providers there.
